{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:31:00Z","timestamp":1792672260994,"version":"4.5.0"},"reference-count":41,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2016,11,22]]},"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Parkinson\u2019s Disease (PD) psychosis refers to the spectrum of illusions, formed hallucinations and delusions that occur in PD. Visual hallucinations and illusions are thought to be caused by specific cognitive and higher visual function deficits and patients who develop such symptoms early in the disease course have greater rates of cognitive decline and progression to dementia. To date, no studies have investigated whether such deficits are found prior to the onset of PD psychosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Here we compare baseline cognitive, biomarker (structural imaging and cerebrospinal fluid) and other PD psychosis risk factor data in patients who go on to develop illusions or hallucinations within 3\u20134 years of follow-up in the Parkinson\u2019s Progression Markers Initiative cohort of newly diagnosed PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of n=423 patients with PD, n=115 (27%) reported predominantly illusions with the median time of onset at 19.5 months follow-up. At study entry these patients had reduced CSF amyloid A\u00df\n                      <jats:sub>1-42<\/jats:sub>\n                      , lower olfaction scores, higher depression scores and increased REM sleep behaviour disorder symptoms compared to patients without early onset PD psychosis but no differences in cognitive, higher visual or structural imaging measures. A subset of patients with early onset formed hallucinations (n=21) had reduced higher visual function at baseline, cortical thinning in parietal, occipital and frontal cortex and reduced hippocampal volume.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The findings suggest early onset illusions and formed hallucinations are linked to amyloid pathology in PD and point to a difference in the underlying pathophysiological mechanism of illusions and formed hallucinations, with implications for their respective links to future cognitive decline.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2016-314832","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T03:20:34Z","timestamp":1489807234000},"page":"325-331","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":92,"title":["Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative"],"prefix":"10.1136","volume":"88","author":[{"given":"Dominic H","family":"ffytche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana B","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Ray","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Aarsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,3,17]]},"reference":[{"key":"2024031200251434000_88.4.325.1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21382"},{"key":"2024031200251434000_88.4.325.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2009.08.014"},{"key":"2024031200251434000_88.4.325.3","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26432"},{"key":"2024031200251434000_88.4.325.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2014.10.033"},{"key":"2024031200251434000_88.4.325.5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.parkreldis.2013.04.021","article-title":"Delusional misidentification syndrome and other unusual delusions in advanced Parkinson's disease","volume":"19","author":"Moro","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"2024031200251434000_88.4.325.6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.11.2227"},{"key":"2024031200251434000_88.4.325.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2000.tb06891.x"},{"key":"2024031200251434000_88.4.325.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2007.05.009"},{"key":"2024031200251434000_88.4.325.9","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.166"},{"key":"2024031200251434000_88.4.325.10","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.3.387"},{"key":"2024031200251434000_88.4.325.11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000842"},{"key":"2024031200251434000_88.4.325.12","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1212\/WNL.0b013e3181bf992f","article-title":"Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort","volume":"73","author":"Uc","year":"2009","journal-title":"Neurology"},{"key":"2024031200251434000_88.4.325.13","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-300043"},{"key":"2024031200251434000_88.4.325.14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jns.2015.06.037","article-title":"Cognitive and neuroanatomical correlates of neuropsychiatric symptoms in Parkinson's disease: a systematic review","volume":"356","author":"Alzahrani","year":"2015","journal-title":"J Neurol Sci"},{"key":"2024031200251434000_88.4.325.15","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/703924"},{"key":"2024031200251434000_88.4.325.16","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22873"},{"key":"2024031200251434000_88.4.325.17","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/mds.25641","article-title":"Cortical and subcortical brain atrophy in Parkinson's disease with visual hallucination","volume":"28","author":"Watanabe","year":"2013","journal-title":"Mov Disord"},{"key":"2024031200251434000_88.4.325.18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bandc.2014.03.011","article-title":"Structural brain abnormalities in patients with Parkinson's disease with visual hallucinations: a comparative voxel-based analysis","volume":"87","author":"Gama","year":"2014","journal-title":"Brain Cogn"},{"key":"2024031200251434000_88.4.325.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-008-0885-8"},{"key":"2024031200251434000_88.4.325.20","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-303391"},{"key":"2024031200251434000_88.4.325.21","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.parkreldis.2014.06.018","article-title":"Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations","volume":"20","author":"Jacobson","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"2024031200251434000_88.4.325.22","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf251"},{"key":"2024031200251434000_88.4.325.23","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23411"},{"key":"2024031200251434000_88.4.325.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2013.11.017"},{"key":"2024031200251434000_88.4.325.25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2015.11.018","article-title":"Interactions of visual hallucinations, rapid eye movement sleep behavior disorder and cognitive impairment in Parkinson's disease: a review","volume":"22","author":"Lenka","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"2024031200251434000_88.4.325.26","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2009.62"},{"key":"2024031200251434000_88.4.325.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2011.09.005"},{"key":"2024031200251434000_88.4.325.28","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24893"},{"key":"2024031200251434000_88.4.325.29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.parkreldis.2016.02.013","article-title":"Olfactory impairment predicts cognitive decline in early Parkinson's disease","volume":"25","author":"Fullard","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"2024031200251434000_88.4.325.30","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000483"},{"key":"2024031200251434000_88.4.325.31","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3233\/JPD-150682","article-title":"Associations between cerebrospinal fluid biomarkers and cognition in early untreated Parkinson's disease","volume":"5","author":"Skogseth","year":"2015","journal-title":"J Parkinsons Dis"},{"key":"2024031200251434000_88.4.325.32","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1007\/s00415-015-7687-6","article-title":"On visual hallucinations and cortical networks: a trans-diagnostic review","volume":"262","author":"Carter","year":"2015","journal-title":"J Neurol"},{"key":"2024031200251434000_88.4.325.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2015.04.005"},{"key":"2024031200251434000_88.4.325.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2011.06.019"},{"key":"2024031200251434000_88.4.325.35","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23896"},{"key":"2024031200251434000_88.4.325.36","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23891"},{"key":"2024031200251434000_88.4.325.37","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu094"},{"key":"2024031200251434000_88.4.325.38","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.10.2055"},{"key":"2024031200251434000_88.4.325.39","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000801"},{"key":"2024031200251434000_88.4.325.40","doi-asserted-by":"publisher","DOI":"10.1097\/JGP.0b013e31821f1b41"},{"key":"2024031200251434000_88.4.325.41","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.4.733"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2016-314832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T03:26:07Z","timestamp":1710213967000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2016-314832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,17]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,3,17]]},"published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1136\/jnnp-2016-314832"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2016-314832","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,17]]}}}